Zoledronic acid monohydrate
Cat. No.：YN280068
CAS No. ：165800-06-6
| 产品名称: | Zoledronic acid monohydrate |
| CAS No.: | 165800-06-6 |
| Chemical Name: | P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-phosphonic acid, monohydrate |
| Synonyms: | 唑来膦酸一水合物; Zoledronate monohydrate; CGP 42446 monohydrate; CGP42446A monohydrate; ZOL 446 monohydrate |
| 分子量: | 290.10 |
| 分子式: | C₅H₁₂N₂O₈P₂ |
| SMILES: | OC(P(O)(O)=O)(P(O)(O)=O)CN1C=CN=C1.[H]O[H] |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Zoledronic acid monohydrate 是第三代含氮二磷酸盐，能够抑制破骨细胞介导的骨吸收，同时具有抗肿瘤的活性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Li, E.C., and David, L.E.Zoledronic acid: A new parenteral bisphosphonateClin. Ther.25(11),2669-2708(2003)
Nancollas, G.H., Tang, R., Phipps, R.J., et al.Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatiteBone38(5),617-627(2006)
Räkel, A., Boucher, A., and Ste-Marie, L.G.Role of zoledronic acid in the prevention and treatment of osteoporosisClin. Interv. Aging6,89-99(2011)
El-Amm, J., Freeman, A., Patel, N., et al.Bone-targeted therapies in metastatic castration-resistant prostate cancer: Evolving paradigmsProstate Cancer2013,1-10(2013)
Major, P.The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancyOncologist7(6),481-491(2002)
Michou, L., and Brown, J.P.Emerging strategies and therapies for treatment of Paget's disease of boneDrug Des. Devel. Ther.5,225-239(2011)
